Untitled Document

 

ACO Name and Location

Health Point ACO, LLC
2055 Wood Street, Suite 100
Sarasota, Florida 34237

ACO Primary Contact

Primary Contact Name

Neil Bedi, CEO

Primary Contact Phone Number

941-284-7264

Primary Contact Email Address

nbedi@hpphealth.com

Organizational Information

ACO participants:

ACO Participants

ACO Participant in Joint Venture (Enter Y or N)

Florida Medical Specialists, LLC.

N

 

 

 

 

 

ACO governing body:

Member

Member’s Voting Power

Membership Type

ACO Participant TIN Legal Business Name/DBA, if Applicable

Last Name

First Name

Title/Position

BLANKENSHIP

THOMAS

CHAIRMAN

 

ACO Participant Representative

Florida Medical Specialists, LLC

BEDI

INITA

SECRETARY

 

ACO Participant Representative

Florida Medical Specialists, LLC

MISHNER

HARVEY

DIRECTOR

 

ACO Participant Representative

Florida Medical Specialists, LLC

BRUNNER

JOSEPH

DIRECTOR

 

Medicare Beneficiary Representative

Florida Medical Specialists, LLC

Key ACO clinical and administrative leadership:

Neil Bedi

ACO Executive

Aruna Narasimman

Medical Director

Neil Bedi

Compliance Officer

Neil Bedi

Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name

Committee Leader Name and Position

Compliance Committee

Dr. Scott Clulow-Chairman

Quality Oversight Committee

Dr. Daniela Kassabov-Chairman

ACO Participant Review Committee

Dr. Werther Marciales-Chairman

Care Coordination Committtee

Dr. Shahnaz Ahmed-Chairman

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement
  •  Networks of individual practices of ACO professionals

 

 

 

Shared Savings and Losses

Amount of Shared Savings/Losses

  • First Agreement Period
    • Performance Year 2016, $3,239,297
    • Performance Year 2015, $0
    • Performance Year 2014, $0

Shared Savings Distribution

  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: 0%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 50% to ACO Participants & 10% to ACO Providers/suppliers.
    • Performance Year 2015
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2014
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2016 Quality Performance Results:

ACO#

Measure Name

Rate

ACO Mean

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

72.12

79.9

ACO-2

CAHPS: How Well Your Providers Communicate

87.9

92.63

ACO-3

CAHPS: Patients’ Rating of Provider

88.19

91.93

ACO-4

CAHPS: Access to Specialists

81.26

83.52

ACO-5

CAHPS: Health Promotion and Education

63.81

60

ACO-6

CAHPS: Shared Decision Making

75.4

75.28

ACO-7

CAHPS: Health Status/Functional Status

74.62

71.82

ACO-34

CAHPS: Stewardship of Patient Resources

27.04

27.52

ACO-8

Risk-Standardized, All Condition Readmission

14.65

14.7

ACO-35

Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)

19

18.17

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes

54.72

53.2

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure

76.59

75.23

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

58.12

59.81

ACO-9

Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)

10.84

9.27

ACO-10

Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 )

15.92

14.53

ACO-11

Percent of PCPs who Successfully Meet Meaningful Use Requirements

84

82.72

ACO-39

Documentation of Current Medications in the Medical Record

94.05

87.54

ACO-13

Falls: Screening for Future Fall Risk

78.63

64.04

ACO-14

Preventive Care and Screening: Influenza Immunization

60.8

68.32

ACO-15

Pneumonia Vaccination Status for Older Adults

70.8

69.21

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up

80.98

74.45

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

93.31

90.98

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

69.18

53.63

ACO-19

Colorectal Cancer Screening

59.67

61.52

ACO-20

Breast Cancer Screening

70.11

67.61

ACO-21

Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented

86.77

76.84

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

74.19

77.72

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

12.71

18.24

ACO-41

Diabetes: Eye Exam  

36.61

44.94

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

70.21

70.52

ACO-30

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

76.54

85.05

ACO-31

Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

84.85

88.67

ACO-33

Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)

80.36

79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Note: In the Quality Performance Results file(s) above, search for “Health Point ACO, LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A81718 in the public use files on data.cms.gov.

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.